Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitemodulationtherape...
CategoryBioTech
Emailinfo@modulationth...
Employees

Offices

Tampa, USA
3802 Spectrum Blvd
Suite #124
Tampa, FL, 33612
USA

Funding

VENTURE FUNDING
Venture Round, 2/2013
Institute for the Commercialization of Public Research

Tags

Modulation Therapeutics

Modulation Therapeutics is dedicated towards the rapid and cost effective advancement of early stage first in class molecules targeting the tumor microenvironment. Tumors that home or metastasize to the bone are typically difficult to treat with standard chemotherapy. We propose that strategies to eradicate tumors that home or metastasize to the bone marrow compartment must include disrupting tumor-host interactions. Our lead compound MTI-101 targets CD44, a cell adhesion molecule required for homing to the bone. Our compound shows activity as a single agent using myeloma in vivo models. We project IND filing of our lead compound MTI-101 in the fourth quarter of 2013. Our goal is to develop the lead compound for the treatment of Myeloma a plasma cell tumor which homes to the bone and a disease which currently has no curative therapies available

Recent Milestones

Videos

Screenshots

Sources

  1. Modulation Therapeutics Receives Funding (finsmes.com) [edit]
Edit This Page
Last Edited 2/14/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy